Complexes of pyridoxal thiosemicarbazones formed with vanadium(IV/V) and copper(II): solution equilibrium and structure by Jakusch, Tamás et al.
1 
 
Complexes of pyridoxal thiosemicarbazones formed with vanadium(IV/V) 
and copper(II): solution equilibrium and structure  
 
Tamás Jakuscha*, Károly Kozmaa, Éva A. Enyedya, Nóra V. Mayb, Alexander Rollerc, 
Christian R. Kowol
c,d
, Bernhard K. Keppler
c,d, Tamás Kissa,e* 
  
a Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary  
b 
Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar Tudósok körútja 2., H-1117 
Budapest, Hungary 
c 
Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Str. 42, A-1090 
Vienna, Austria 
d Research Cluster “Translational Cancer Therapy Research” University of Vienna, Waehringer Str. 42, A-1090 
Vienna, Austria 
e
 MTA-SZTE Bioinorganic Chemistry Research Group, University of Szeged, Dóm tér 7, H-6720 Szeged, 
Hungary 
 
 
Dedicated to Prof. Imre Sóvágó on the occasion of His 70th birthday 
 
 
 
Keywords: Stability Constants; X-ray Crystal Structure; Thiosemicarbazone, Pyridoxal, Vanadium, 
Copper 
 
 
 
 
* Corresponding authors: Fax: +36 62 420505 
E-mail addresses: tkiss@chem.u-szeged.hu (T. Kiss), jakusch@chem.u-szeged.hu (T. 
Jakusch) 
  
2 
 
ABSTRACT 
The stoichiometry and thermodynamic stability of vanadium
IV/V
 and copper
II
 complexes 
of pyridoxal thiosemicarbazone and pyridoxal-N
3
,N
3
-dimethylthiosemicarbazone have been 
determined by pH-potentiometry (V
IV
O), EPR (V
IV
O/Cu
II
), UV-Vis (Cu
II
, V
IV
O and V
V
) and 
51
V-NMR spectroscopy (V
V
) in 30% (w/w) dimethyl sulfoxide/water solvent mixture. In all 
cases, mono-ligand complexes are formed in different protonation states. In addition, the 
proton-dissociation constants of the ligands were also determined by pH-potentiometry, UV-
Vis and 
1
H-NMR spectroscopy. The solid state structures of the monoprotonated forms 
(V
V
O2(L
1
H)×0.8H2O and V
V
O2(L
2
H)×0.8H2O) of the V
V
 complexes were characterized by 
single-crystal X-ray diffraction analysis. The mono-ligand complexes of Cu
II
 and V
V
 are 
dominant at physiological pH. With all investigated metal ions the pyridoxal moiety of the 
ligand causes an extra deprotonation step between pH 4 and 7 due to the non-coordinating 
pyridine-NH
+
. The pyridoxal-containing ligands form somewhat more stable complexes with 
both V
IV
O and Cu
II
 ions than the reference compound salicylaldehyde thiosemicarbazone. 
Dimethylation of the terminal amino group resulted in the formation of V
V
 and Cu
II
 
complexes with even higher stability. 
 
1. Introduction 
Thiosemicarbazones (TSCs) and their metal complexes are highly interesting scaffolds 
as they exhibit a wide range of pharmacologically important properties like anticancer, 
antibacterial, antiparasitic, and antiviral effects [1]. TSCs are hydrazones obtained by 
condensation of a thiosemicarbazide with an aldehyde or a ketone. When a coordinating 
functional group is additionally present in the proper position of the aldehyde/ketone the 
TSCs are able to coordinate in a tridentate way. The most prominent representative of this 
family is the α(N)-heterocyclic Triapine (3-aminopyridine-2-carbaldehyde 
thiosemicarbazone) that has demonstrated promising activity mainly in hematological 
malignancies [2-4]. The stability of the metal complexes formed with the TSCs strongly 
depends on the character of the metal ion, the additional functional group and the position and 
type of the substituents at the TSC backbone [5,6]. The presence of a phenolic OH group at a 
chelatable position, like in salicylaldehyde thiosemicarbazone (STSC), might provide a 
different and more favourable coordination for harder metal ions preferring oxygen donor 
atoms like Fe(III), Ga(III) etc. Notably, numerous metal complexes of STSC and its 
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derivatives were prepared and tested in vitro on various cancer and tuberculosis cell lines, as 
well as parasites and pathogenic bacteria [7-9].  
  
Scheme 1. Chemical structures of the thiosemicarbazones investigated in this study. 
Interesting derivatives of STSC can be synthesized using the B6 vitamin related 
pyridoxal (3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde) instead of 
salicylaldehyde. Complexes of pyridoxal thiosemicarbazone (PxTSC, Scheme 1) or its 
derivatives were already prepared with a wide range of metal ions such as divalent and 
trivalent 3d metal ions, e.g. Zn
II
/Cu
II
/Ni
II
 [10-12] or Fe
III
/Cr
III
 [13,14], dioxido cations like 
U
VI
O2/Mo
VI
O2/V
V
O2 [15-17], the platinum group metal ions Pd
II
/Ru
II
 [18-19] and 
organometallic ions (e.g. dimethyl-Sn
IV
) [20]. In these complexes the PxTSC or its derivatives 
coordinate in a tridentate mode (except a few cases e.g. Au
III 
[21] or dimethyl-Tl
III
 [22] with 
bidentate coordination). The exact composition of the complexes depends on the coordination 
properties of the metal ion. Bis-ligand complexes are formed with e.g. Fe
III
 [23], Co
III
 [24] 
and Ni
II
 [25], when an octahedral coordination mode is preferred. In case of Cu
II
 mainly 
mono-ligand complexes were described [11,26,27] sometimes in dimerized form [13]. The 
PxTSC and derivatives are usually coordinated in these complexes in their zwitterionic (H2L 
with O
–
,N,S coordination) or in their anionic (HL
–
 with O
–
,N,S
– 
coordination) forms (Scheme 
2). It means that the phenolate is always deprotonated and coordinated, the pyridoxal-N atom 
is protonated, but the protonation state of the hydrazinic N
2
H depends on the actual 
conditions. To our knowledge, there are only two exceptions: [Ni(LH)2]×2H2O [25] and 
[Cu(LH)MeOH]Cl [26] complexes (LH2 = PxTSC) in which the pyridoxal-N is deprotonated 
while the hydrazinic N
2
H is still protonated. 
The biological activity of various PxTSC-based compounds including metal complexes 
was investigated [13,26-30], however, most of these studies are focused on the cytotoxic 
activity of Cu
II
 complexes. A recent study demonstrated the promising cytotoxic activity of 
Cu
II
 complexes of PxTSC and its two N-terminally methyl/phenyl monosubstituted 
derivatives against human cervical (HeLa), human breast (MCF-7) and human liver 
carcinoma (Hep G2) cancer cell lines without affecting the noncancerous NIH 3T3 mouse 
N1
N2 N3H2
SN4
OH
OH
PxTSC = L1H2 PxTSCm = L
2H2
H
N1
N2 N3
SN4
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OH
H
4 
 
embryonic fibroblast cells [26]. These complexes were found to bind to DNA via partial 
intercalation or groove binding, and induced apoptosis which involved reactive oxygen 
species generation [26]. Belicchi Ferrari et al. reported on monomeric [Cu(LH2)(OH2)Cl]Cl 
and dinuclear [(Cu(LH)(OH2))2]Cl2×2H2O) complexes of PxTSC possessing inductive effect 
on erythroleukemia cell erythroid differentiation, although in both cases the monomeric forms 
were assumed to be the active species [27]. Also the dimeric Cu
II 
complex of the N-terminally 
dimethylated derivative of PxTSC (pyridoxal-N
3
,N
3
-dimethylthiosemicarbazone, PxTSCm = 
L
2
H2) were investigated and its behaviour was evaluated on U937, CEM and K562 human 
cancer cell lines exhibiting, however, only weak proliferation inhibition [13]. 
Furthermore, also the antiamoebic activity of V
V
O2 complexes of PxTSC and some 
derivatives was tested against HM1:1MSS strains of Entamoeba histolytica. The most 
promising compound could efficiently inhibit the growth of this parasitic amoebozoa (IC50 = 
0.5 μM) [30]. Additionally, it should be noted that some of the metal complexes of PxTSC 
have interesting catalytic activity as well [18,19,31-33]. 
Notably, also the related compound class of pyridoxal isonicotinoyl hydrazones (PIH) 
show pronounced antitumor activity due to their efficient iron chelation ability and a series of 
thiosemicarbazone-based compounds related to PIH have been also described as potent 
antiproliferative agents [29]. 
Despite of the numerous reports on the synthesis, solid state characterization and 
biological activity tests of various pyridoxal thiosemicarbazone metal complexes, there is no 
information available on the species present in aqueous solution at physiological pH and their 
thermodynamic stability. Complex formation processes and solution stabilities of complexes 
of the reference compound salicylaldehyde thiosemicarbazone (STSC) with various metal 
ions Zn
II
, Cu
II
, Fe
II,III
, Ga
III
 [34], V
IV
O and V
V 
[35] have been already recently described in 
detail by our group. These data indicated that in some cases (e.g. V
IV
O) the stability of the 
STSC complexes was not high enough to hinder the complex decomposition at physiological 
pH. Consequently, herein we investigated the effect of the replacement of the salicylaldehyde 
moiety to pyridoxal on the solution speciation of the complexes formed with copper(II) and 
vanadium(IV/V) ions expecting an increased stability. For this reason detailed solution 
equilibrium studies were performed on the Cu
II
, V
IV
O and V
V
 complexes formed with PxTSC 
and its N
3
-terminally dimethylated derivative PxTSCm by means of pH-potentiometry and 
UV-Vis-, EPR- and 
51
V-NMR-spectroscopies. 
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2. Experimental 
2.1. Chemicals 
All solvents used for the synthesis were of analytical grade and used without further 
purification. Pyridoxal hydrochloride (Fluka), thiosemicarbazide (Fluka), 4,4-dimethyl-3-
thiosemicarbazide (Fluka), NaVO3, V
IV
OSO4, KOH, D2O and DMSO-d6 were purchased 
from Sigma-Aldrich and CuCl2 from Reanal, KCl, HCl and DMSO from Molar Chemicals. 
The V
IV
O stock solution was prepared as described [36] and standardized for the metal ion 
concentration by permanganate titration. Vanadate stock solution was prepared by dissolving 
V2O5 in KOH solution and its concentration was calculated based on its mass and the total 
volume. CuCl2 was dissolved in water in order to get the Cu
II
 stock solution and its 
concentration was determined by complexometry via the EDTA complex. Double distilled 
Milli-Q water was used for sample preparations. All the solutions were prepared that the 
DMSO content was 30% (w/w), except in the NMR samples, where DMSO 30% (v/v) H2O 
60% (v/v) and D2O 10% (v/v) were applied. 
The purity and aqueous phase stability of the studied ligands was verified and the exact 
concentration of their stock solutions together with the proton dissociation constants were 
determined by pH-potentiometric titrations with the aid of the computer program pHCali [37]. 
2.2. Synthesis of the ligands and their V
V
- complexes 
The ligands (PxTSC, PxTSCm) were synthesized based on literature methods [38,28] 
and slightly modified. In both cases the aldehyde group of the pyridoxal reacts with the 
hydrazine moiety of the given thiosemicarbazone. However, before the condensation reaction 
the hydrochloride form of the pyridoxal should be neutralized. In our case KOH was used for 
that process and the neutral form of the pyridoxal precipitated from the aqueous solution. This 
solid was filtered off, dried and used for further processes. 
The PxTSC was synthesized based on Ref. [38]. 0.56 g of thiosemicarbazide 
(6.14 mmol) in 15 mL of ethanol was added to a solution of 1.00 g of neutral pyridoxal 
(5.98 mmol) in 75 mL of ethanol, and the mixture was refluxed for 2.5 h. After cooling, the 
obtained yellow powder was filtered, and recrystallized from hot water, and dried in vacuo. 
1
H-NMR in H2O/D2O 90-10% (v/v) [ppm]: 8.42 (s, 1H), 7.83 (s, 1H), 2.43 (s, 3H). (The 
signal of the pyridoxal –CH2-OH part could not be observed, because of the water signal 
saturation.) 
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The PxTSCm was synthesized based on Ref. [28]. 0.73 g of N
3
,N
3
-dimethyl-3-
thiosemicarbazide (6.13 mmol) was added to a solution of 1.02 g of neutral pyridoxal 
(6.10 mmol) in 250 mL of methanol, and the mixture was let to stand at room temperature for 
50 min. After evaporation of the solvent the residue was recrystallized from methanol, and 
dried in vacuo. 
1
H-NMR in H2O/D2O 90-10% (v/v) [ppm]: 8.64 (s, 1H), 7.90 (s, 1H), 3.26 (s, 
6H), 2.47 (s, 3H). (The signal of the pyridoxal –CH2-OH part cannot be observed, because of 
the water signal saturation.) 
X-ray diffraction quality single crystals of [V
V
O2(L
1
H)]×1.5H2O×0.15CH3OH (1) and 
[V
V
O2(L
2
H)]×0.8H2O (2) were obtained (PxTSC = L
1
H2 and PxTSCm = L
2
H2) by slow 
evaporation of a mixture of the ligand (1 eq) and [V
V
2O4(acac)2] [39] (0.5 eq) in MeOH/H2O 
(2:1 for 1 and 1:1 for 2). 
2.3. Crystallographic structure determination 
X-ray diffraction measurements were performed on a Bruker X8 APPEXII CCD 
diffractometer. A single crystal of suitable size was coated with Paratone-N oil, mounted at 
room temperature on a cryo loop and cooled under a stream of cold N2 maintained by a 
KRYOFLEX low-temperature apparatus. The crystals of 1 and 2 were positioned at 40 mm 
from the detector, and 1986/1638 frames were measured, each for 20 s over 1° scan width. 
The data were processed using SAINT software [40]. The structures were solved by direct 
methods and refined by full-matrix least-squares techniques. Non-hydrogen atoms were 
refined with anisotropic displacement parameters. H atoms were placed at calculated positions 
and refined as riding atoms in the subsequent least squares model refinements. For 1 a volume 
of 38.9 Å3 per asymmetric unit was masked. Two different types of disorder could be 
modeled: one with water, the other one with MeOH, both in the range of 15-20% occupancy. 
Disorder was found in 2 for O4 and the protons on O4 and C11 with a distribution of 
0.80:0.20. In order to stabilize the anisotropic displacements and the bond length, the bonds 
were restrained with SADI and DFIX instructions. The following software programs and 
computer were used: structure solution: SHELXS-97 [41]; refinement: SHELXL-97 [41];
 
OLEX2 [42], molecular diagrams: ORTEP [43]. Crystal data and structure refinement details 
for 1 and 2 are given in Table S1. 
2.4. pH-potentiometric measurements 
The pH-metric measurements for determination of the protonation constants of the 
ligands and the overall stability constants of the vanadium
IV
 complexes were carried out at 
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25.0°C in DMSO : water 30 : 70 (w/w) as solvent and at an ionic strength of 0.10 M (KCl) in 
order to keep the activity coefficients constant. The same solvent mixture was always used in 
our previous studies on various TSCs [5,6,34,35,44,45]. The titrations were performed with 
carbonate-free KOH solution of known concentration (0.10 M). The concentrations of the 
base and the HCl were determined by pH-potentiometric titrations. An Orion 710A pH-meter 
equipped with a Metrohm combined electrode (type 6.0234.100) and a Metrohm 665 Dosimat 
burette were used for the pH-metric measurements. The electrode system was calibrated to the 
pH = −log[H+] scale in the DMSO/water solvent mixture by means of blank titrations (strong 
acid vs. strong base; HCl vs. KOH), similarly to the method suggested by Irving et al. [46]. 
The average water ionization constant, pKw, is 14.52 ± 0.05 in the DMSO/water 30:70 (w/w) 
solvent at 25°C, which corresponds well to the literature data [47]. The reproducibility of the 
titration points included in the calculations was within 0.005 pH. The pH-metric titrations 
were performed in the pH range 2.0 − 12.5. The initial volume of the samples was 25.0 mL. 
The ligand concentration was 2 or 1 mM and metal ion-to-ligand ratios of 1:1 − 1:4 were 
used. The accepted fitting of the titration curves was always less than 0.01 mL (the average 
difference between the experimental and the calculated titration curves expressed in the 
volume of the titrant). Samples were deoxygenated by bubbling purified argon through them 
for ca. 10 min prior to the measurements. In the case of V
IV
O-containing
 
samples, argon 
overpressure was used when metal ion solution was added to the samples in tightly closed 
vessels, which were prior completely deoxygenated by bubbling a stream of purified argon 
through them for ca. 20 min. Argon was also passed over the solutions during the titrations. 
The protonation constants of the ligands were determined with the computer program 
pHCali [37]. PSEQUAD [48,49] was utilized to establish the stoichiometry of the complexes 
and to calculate the stability constants (log(MpLqHr)) (MpLqHr) is defined for the general 
equilibrium pM + qL + rH MpLqHr as (MpLqHr) = [MpLqHr]/[M]
p
[L]
q
[H]
r
, where M 
denotes the metal ion and L the completely deprotonated form of the ligand. In all 
calculations exclusively titration data were used from experiments, in which no precipitate 
was visible in the reaction mixture. 
In order to evaluate the solution equilibrium data hydrolysis constants of the studied 
metal ions are needed, however in such special conditions, as DMSO : water 30:70 (w/w), 
these constants are not available. In the case of Cu(II), where no free metal ion were observed 
in the whole pH-range the lack of hydrolysis constants does not mean a problem. In the 
51
V-
NMR spectra only V1 was observed as free “metal ion” and no oligomers (V2/V4/V5/V10) 
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were detected. The pKa = 9.36 of the H2VO4
–
 were determined from the 
51
V-NMR chemical 
shift data [35]. 
Unfortunately the V
IV
O ions most probable started to hydrolyse at pH > 4-5. Accurate 
determination of the stoichiometry and stability constants of V
IV
O complexes formed parallel 
with the hydrolysis is a rather hard task in water organic solvent mixtures due to the 
complicated processes such as slow, non-reversible oligomerisation and partial oxidation of 
V
IV
O. Accordingly, pH ranges, where such processes may take place were omitted from the 
evaluation. 
 
2.5. UV–Vis spectrophotometric measurements 
A Hewlett Packard 8452A diode array spectrophotometer was used to record the UV–
Vis spectra in the interval 250–820 nm. The pathlength was 1.0 cm or 2.0 mm. The 
spectrophotometric titrations were performed on samples of the TSCs alone or with V
V
, Cu
II
; 
the concentration of ligand was 0.5 (TSCs alone and TSCs-V
V
) or 0.1 mM (TSCs alone and 
TSCs-Cu
II
) and the metal-to-ligand ratios were 1:1, 1:1.5 and 1:2 over the pH range between 2 
and 12 at an ionic strength of 0.10 M KCl in 30% (w/w) DMSO/H2O at 25.0 ± 0.1 
o
C. TSCs, 
at 2 mM, were titrated with V
IV
O at pH 4.40. Spectra were also recorded for the Cu
II
 – ligand 
systems at 1:1 metal-to-ligand ratio by preparing individual samples in which KCl was 
partially or completely replaced by HCl and pH values, varying in the range ca. 0.1–3.0, were 
calculated from the strong acid content. 
Protonation and stability constants and the individual spectra of the species were 
calculated by the computer program PSEQUAD [48,49]. 
2.6. 
1
H- and 
51
V-NMR measurements 
The pH-dependent 
1
H- and 
51
V-NMR studies were carried out on a Bruker Avance 
DRX500 instrument. For the 
51
V-NMR measurements a spectral window of 760 ppm, a 90
◦
 
pulse angle and an acquisition time of 0.65 s with a relaxation delay of 0.5 s and a pulse width 
of 7 ms were applied. 4,4-dimethyl-4-silapentane-1-sulfonic acid was used as an internal 
1
H-
NMR standard and V
V
OCl3 (90% in C6D6) was used as an external 
51
V-NMR reference. 
The TSCs were dissolved in 30% (v/v) DMSO 60% H2O and 10% D2O at 25 
o
C in a 
concentration of 1.25 or 2 mM and the V
V
O2-to-ligand ratios were 1:1 or 1:2. Samples 
contained 0.10 M KCl. Overall stability or stepwise constants for the complex formation 
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equilibria were determined with the aid of the computer program PSEQUAD [48,49] on the 
basis of the integral values and chemical shifts. 
2.7. EPR measurements and deconvolution of the spectra 
X-band-EPR spectra were recorded with a BRUKER EleXsys E500 spectrometer 
(microwave frequency 9.5-9.8 GHz, microwave power 10-12 mW, modulation amplitude 5 G, 
modulation frequency 100 kHz). EPR spectra were recorded on a sample (I = 0.10 M KCl in 
30% (w/w) DMSO/H2O) prepared by titration under nitrogen atmosphere. KOH solution was 
added to the solution to adjust the pH which was measured with a Radiometer PHM240 
pH/ion Meter equipped with a Metrohm 6.0234.100 glass electrode. For Cu
II
 1:1 Cu
II
-to-
ligand ratio at 0.1 mM ligand concentration were applied, the pH was varied between 2 and 6. 
In the case of V
IV
O 1:1, 1:2 and 1:3 ratio have been measured, the applied ligand 
concentration were 3.0/2.0/1.33 mM, depending on the solubility properties of the system, the 
pH was varied from 2 to 8. 
For V
IV
O–ligand systems the isotropic EPR spectra were recorded during a titration, at 
25°C, in a circulating system. A Heidolph Pumpdrive 5101 peristaltic pump was used to 
circulate the solution from the titration pot through a capillary tube into the cavity of the 
instrument. These spectra were simulated by the ’two-dimensional’ method using the 2D EPR 
program [50]. The g0, and A0 V (I =7/2) oxovanadium(IV) hyperfine coupling parameters 
were taken into account to describe each component curve. The relaxation parameters, α, β, 
and γ, defined the line widths through the equation σMI=α+βMI+γMI
2
, where MI denotes the 
magnetic quantum number of the paramagnetic metal ions. 
For the frozen solution measurements (Cu
II
/V
IV
O) 0.1 mL of sample was taken out of the 
solution at various pH values and was measured individually in a dewar containing liquid 
nitrogen (at 77 K). 0.02 mL of methanol was added to the samples to avoid water 
crystallization. The anisotropic spectra were analyzed individually with the EPR program 
[51], which gives for Cu
II
 the anisotropic EPR parameters gx, gy, gz (rhombic g-tensor), Ax
Cu
, 
Ay
Cu
, Az
Cu
 (rhombic copper hyperfine tensor) and Ax
N
, Ay
N
, Az
N
 (rhombic nitrogen 
superhyperfine tensor) and the orientation dependent line width parameters. All tensors were 
supposed as coaxial. For the V
IV
O complexes gǀǀ, g axial g-tensor and Aǀǀ, A axial hyperfine 
tensor were taken into consideration. In the case of Cu
II
 only the complexes of PxTSC were 
studied due to solubility problems with the other ligand. 
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Since a natural CuCl2 was used for the measurements, the spectra were calculated as the 
sum of the spectra of 
63
Cu and 
65
Cu weighted by their natural abundances. The quality of fit 
was characterized by the noise-corrected regression parameter Rj as above. The details of the 
statistical analysis were published previously [51]. The copper, vanadium and nitrogen 
coupling constants and the relaxation parameters were obtained in field units (Gauss = 10
−4
 
T), the first two were converted to energy related units (10−4 cm-1). 
 
3. Results and discussion 
3.1. X-ray structure of the vanadate complexes 
The results of single crystal X-ray diffraction studies on complexes 
[V
V
O2(L
1H)]×0.8H2O (1) and [V
V
O2(L
2H)]×0.8H2O (2) are shown in Figs. 1 and 2 (selected 
bond distances and angles are quoted in the legends of the Figs). For both vanadium(V) 
complexes the coordination polyhedron around the metal ion is intermediate between square-
pyramidal and trigonal-bipyramidal with τ = 0.26 for 1 and τ = 0.20 for 2, respectively (τ = 1 
for an ideal trigonal bipyramid, τ = 0 for an ideal square pyramid) [52]. The vanadium atom is 
coordinated by one tridentate thiosemicarbazone ligand via the phenolate oxygen atom, the 
nitrogen and sulfur donors of the thiosemicarbazide moiety and two oxido ligands with bond 
lengths in the expected range for such type of complexes [53,54]. 
In both crystal structures the thioamide NH is deprotonated accompanied with a distinct 
elongation of the C7–S bond [1: 1.7352(17); 2: 1.747(2) Å] compared to the metal-free ligand 
(1.70(2) Å) [55] indicating an increased single-bond character. Concomitantly the C7–N2 
bond in Å decreases from 1.35(1) to 1.321(2) in 1 and 1.327(3) in 2, respectively. 
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Fig. 1. ORTEP plot of [V
V
O2(L
1H)]×0.8H2O (1) with thermal ellipsoids depicted at 50% 
probability level (the solvent molecules are omitted). Selected bond distances (Å) and angles 
(deg): V–O1, 1.9053(12); V–O2, 1.6190(13); V–O3, 1.6432(12); V–S1, 2.3471(5); V–N1, 
2.2148(14); S1–C7, 1.7352(17); C7–N2, 1.321(2); N2–N1, 1.3764(19); N1–C6, 1.296(2); 
O1–V–S, 137.84(4); O2–V–O3, 108.59(7), O2–V–N1, 97.08(6); O3–V–N1, 153.23(6). 
The pyridine nitrogen of the pyridoxal moiety is protonated in both X-ray crystal 
structures in accordance with the data of the metal-free ligand [55]. This leads to a 
zwitterionic ligand structure with one positively charged pyridinium nitrogen and the 
negatively charged deprotonated phenolic oxygen and thiolate sulfur atom, generating 
together with the vanadium(V) ion neutral metal complexes. In contrast, vanadium(V) 
complexes with the closely related STSC ligands in the thiolate form are usually positively 
charged [53,54]. 
 
Fig. 2. ORTEP plot of [V
V
O2(L
2H)]×0.8H2O (2) with thermal ellipsoids depicted at 50% 
probability level (the water molecule is omitted). Selected bond distances (Å) and angles 
(deg): V–O1, 1.8935(17); V–O2, 1.6125(17); V–O3, 1.6644(17); V–S1, 2.3429(7); V–N1, 
2.204(2); S1–C7, 1.747(2); C7–N2, 1.327(3); N2–N1, 1.372(3); N1–C6, 1.304(3); O1–V–S, 
142.12(6); O2–V–O3, 107.17(9), O2–V–N1, 97.80(8); O3–V–N1, 153.94(8).  
3.2. Proton dissociation processes of the ligands 
Proton dissociation processes of the ligands (Scheme 2) were followed by pH-
potentiometry, UV–Vis spectrophotometry and 1H-NMR titrations (Fig. S2-S5). 
Measurements were performed in a 30% (w/w) DMSO/H2O solvent mixture. The presence of 
DMSO was required by reason of the limited water solubility of the ligands and their metal 
complexes. Consecutive titrations of both ligands showed that no decomposition occurred in 
the pH range studied under argon atmosphere.  
12 
 
 
Scheme 2. Proton dissociation equilibria, pKa values and tautomerism of the ligands studied. 
Three proton dissociation constants could be determined by various methods (Table S2) 
and constants obtained are in reasonably good agreement. pK1 and pK2 can likely be attributed 
to deprotonation of the pyridoxal moieties: ring nitrogen and phenolic OH. Their 
deprotonation processes are most probably overlapping, although microscopic proton 
dissociation constants determined for 3-hydroxypyridine suggest that pK2 is associated mainly 
with the pyridinium nitrogen [56]. pK3 can be related to the proton dissociation of the N
2
H 
group of the thiosemicarbazide moiety. The last deprotonation step results in a negative 
charge which is mainly localized on the S atom via the thione–thiol tautomeric equilibrium. 
The calculated molar UV-Vis spectra of the individual species are depicted in Fig. S1. 
A half order of magnitude higher pK1 and a slightly lower pK3 was obtained for the N-
terminally dimethylated TSC, while pK2 was almost unchanged. It is noteworthy that also in 
the case of -N-pyridyl TSCs distinct effects of dimethylation on the proton dissociation 
constants were observed, namely the pKa of the pyridinium nitrogen is increased, while pKa of 
the azomethine nitrogen is diminished [5]. Comparing the pKa values of PxTSC to the 
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reference compound STSC it can be concluded that the presence of the pyridoxal nitrogen 
decreases the pKa values of the OH and N
2
H moieties [34].  
The PxTSC and PxTSCm ligands show Z/E isomerism at basic pH values as a new set of 
peaks belonging to the aromatic ring protons appears (Fig. S3/S5). The same phenomenon can 
be observed with the salicylaldehyde semicarbazone ligand (SSC) [45], however does not 
appear in the case of STSC. 
3.3. Solution equilibria of vanadium
V
 complexes 
Only one major signal was observed in the 
51
V-NMR spectra measured for the V
V
-ligand 
systems at the pH range from 2 to 12 (Fig. 3 and Fig. S6) that belongs to a given type of 
complex, and this signal can be observed independently from the ligand excess. The chemical 
shift of the complex formed is changing in the pH range from 2 to 4 indicating a fast chemical 
equilibrium, most probable a deprotonation process. At basic pH, at pH ~9 this complex starts 
to decompose and the signal of the free vanadate (H2VO4
–
/HVO4
2–
) becomes dominant at pH 
> 10. 
Table 1 
51
V-NMR chemical sifts (ppm) assigned to complexes formed in the V
V–PxTSC and VV–
PxTSCm system {T = 25.0°C, I = 0.10 M (KCl) in 30% (v/v) DMSO, 60% (v/v) H2O, 10% 
(v/v) D2O} compared with data published earlier. 
 PxTSC PxTSCm STSC [35] SSC [45] 
Composition I1
a
 I2
a
 I1
a
 I2
a
 I1
a
 I2
a
 I1
a
 I2
a
 
[V
V
O2LH2]
+
 -521 - -520 -  -   
V
V
O2LH -452 -584 -448 - -502    
[V
V
O2L]
–
 -449 -577 -446.5 - -449 -577 -552  
[V
V
O2LH-1]
2–
      -539 -539.5 -575.5 
a
 Isomers 
The difference between the two studied V
V
-ligand systems is marginal; however the 
complexes formed with the N-terminally dimethylated ligand PxTSCm are somewhat more 
stable. 
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Fig. 3. 
51
V-NMR spectra recorded for the V
V–PxTSC system at the indicated pH values {cVV 
= 1.0 mM; V
V 
: L = 1 : 1; T = 25.0°C, I = 0.10 M (KCl) in 30% (v/v) DMSO, 60% (v/v) H2O, 
10% (v/v) D2O}. 
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Fig. 4. Absorbance data at three different wavelengths measured in the V
V–PxTSC system at 
various pH values {cV
V
 = 0.48 mM; V
V 
: L = 1 : 1.05; T = 25.0°C, I = 0.10 M (KCl) in 30% 
(v/v) DMSO, 70% (v/v) H2O}. The symbols represent the experimental data points, the 
continuous lines are fitted curves. 
Besides these two processes which are easily observable in the 
51
V-NMR spectra 
(namely, deprotonation at pH between 1 and 4, decomposition above pH 9) in the UV-Vis 
spectra one more equilibrium process could be detected at pH between 3 and 6 (Fig 4). 
Presumably, this process can be assigned to the deprotonation of the pyridoxal-N, since it has 
most likely the smallest effect on the 
51
V-NMR chemical shift of the formed complexes. For 
both ligands the deprotonation of the N
1
H moiety of [V
V
O2LH2]
+
 results in a similar change 
( = 69/72 ppm) in the 51V-NMR chemical shift as the deprotonation of the [VVO2LH]
+
 
complex of STSC ( = 53 ppm, data in Table 1). 
 
 
Fig. 5. Concentration distribution curves for the V
V–PxTSC system {cVV = 1.0 mM; VV : L = 
1 : 2; T = 25.0°C, I = 0.10 M (KCl) in 30% (w/w) DMSO, 70% (w/w) H2O}. (Dashed lines 
indicate the mole fraction of the isomeric species.) 
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The overall stability constants (Table 2) were calculated using both the 
51
V-NMR and 
UV-Vis titration data; the differences between the results of two methods are not significant 
(Table S3). As illustration the speciation of the systems studied are depicted in Fig. 5 and Fig. 
S7.  
Table 2 
Overall stability (log) and proton dissociation (pKa) and conditional stability (log’) 
constants of the H
+
, V
V
, V
IV
O and Cu
II
 complexes formed with the ligands PxTSC and 
PxTSCm {T = 25.0°C, I = 0.10 M (KCl) in 30% (w/w) DMSO, 70% (w/w) H2O}. 
  PxTSC    PxTSCm  
log         
LH3  23.79(3)    24.19(7)  
LH2  19.71(3)    19.69(7)  
LH  11.66(3)    11.56(6)  
        
pKa        
LH3  4.08(2)    4.50(2)  
LH2  8.05(1)    8.13(3)  
LH  11.66(3)    11.56(6)  
        
log  VVO2 
a
 V
IV
O
 
Cu
II b
  V
V
O2
a
 V
IV
O Cu
II b
 
MLH2 
32.93(5) / 
25.93 
24.03(4) >30.3  
33.79(17) / 
26.79 
24.59(5) >30.3 
MLH 
30.81(4) / 
23.81 
21.06(3) >28.0  
31.80(17) / 
24.80 
21.76(3) >27.7 
ML 
25.66(4) 
/18.66 
16.67(5) >21.7  
26.47(17) / 
19.47 
16.96(5) >22.0 
MLOH - 9.7(3) >10.4  - 9.7(3) >11.8 
        
pKa        
MLH2 2.12(6) 2.97(5) 2.35(9)  1.99(6) 2.83(6) 2.59(2) 
MLH 5.15(6) 4.30(6) 6.22(9)  5.33(6) 4.80(6) 5.74(2) 
ML  7.1(3) 11.32(9)   7.3(3) 10.17(2) 
        
log ’ = pM c 
(pH = 7.4) 
13.7 12.2 >16.7 
 
14.5 12.4 >17.1 
a 
For V
V
 H2V
V
O4
–
 (=MH-2) were used as basic species (data before the slash character). For a comparison with 
the other metal ions the equilibrium constant of the process VO2
+ 
+ 2H2O = H2VO4
–
 + 2H
+ 
should be necessary, 
which is, however, unknown under the applied conditions. An estimation (data after the slash character, M 
=V
V
O2
+
 ) a value of 7.0 was used, it was measured in water (T = 25.0°C and I = 0.15 M NaCl) [57] 
b 
Only threshold limits for the log value of CuII complexes could be estimated (vide supra) 
c 
Conditional stability constants valid for pH = 7.4. In this case if cM : cL = 1:2, then log 
’c
 = pM 
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The possible structures of the formed complexes (where M represents the metal ion) are 
depicted in Scheme 3. Due to the rigid structure of the TSCs only mer coordination is possible 
in a six coordinated octahedral geometry, which would result in hydroxido coordination trans 
to an oxido group. However, such a negatively charged donor group trans to the oxygens of 
V
V
O2 is energetically unfavoured (trans effect). Consequently complexes with ML(OH) 
composition were not observed in case of vanadate. The 
51
V-NMR chemical shifts for the 
complexes of PxTSC/PxTSCm (V
V
O2LH / [V
V
O2L]
–
) and STSC ([V
V
O2L]
–
) are fairly close 
to each other (–446 to –452 ppm, Table 1), showing very similar coordination environment 
around the V
V 
centre. 
 
Scheme 3 Possible structures of the complexes formed between M (V
V
O2 / V
IV
O / Cu
II
) and 
PxTSC (R = H) or PxTSCm (R = Me) (in the case of V
V
 the ML(OH) complex is not formed). 
For PxTSC in the 
51
V-NMR spectra a minor species could be observed at pH between 3 
and 8.5 attributed to the formation of isomers, existing both in forms of [V
V
O2LH] and 
[V
V
O2L]
–
. Based on the chemical shift data (Table 1) the minor isomer (in [V
V
O2L]
–
 form) is 
identical with the previously detected minor species formed with STSC ([V
V
O2L]
–
) and SSC 
([V
V
O2LH-1]
–
) having most probably a (O,N
1
,N
3
) binding mode [35,45]. In these isomers the 
chalcogen donor atoms (O
–
 or S
–
) of the (thio)semicarbazone moiety are non-coordinated. The 
lack of this type of isomer in the case of PxTSCm-V
V
 complexes confirms the suggested 
binding mode, as the N
3
 nitrogen due to the presence of the methyl groups is not able to 
coordinate (Scheme 3). 
3.4. Solution equilibria of vanadium
IV
 complexes 
In the presence of V
IV
O ions slow processes were observed, and the formation of 
hydroxido or ternary hydroxido complexes and their partial oxidation at pH > 5 hindered the 
N N
H
N
S
R
R
HN
O
OH
M
N
N N
S
R
R
HN
O
OH
M
N N N
S
R
R
N
O
OH
M
MLH2
MLH
ML
N
N N
S
R
R
N
O
OH
M
ML(OH)
OH
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pH-potentiometric titrations or any other quantitative study. Both pH-metric and EPR 
measurements (Fig. 6, Fig. S8-9) suggest that at pH 2 the V
IV
O aqua ion dominates, although 
formation of the complex [V
IV
OLH2]
2+
 has already started (Fig. 7 and S10). Two 
deprotonation processes take place up to pH 5 overlapping somewhat to each other (in case of 
PxTSCm this overlap is not so strong). The evaluation of the pH-metric titration data 
suggested the formation of bis-ligand complexes, but detailed UV-Vis spectrophotometric 
measurements confirmed that it was only an artefact. 
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Fig. 6. Measured and simulated EPR spectra recorded for the V
IV
O–PxTSC system at various 
pH values {cV
IV
O = 2.8 mM; V
IV 
: L = 1 : 1.1; RT, I = 0.10 M (KCl) in 30% (w/w) DMSO, 
70% (w/w) H2O}. 
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Table 3  
EPR parameters of the complexes formed in the V
IV
O - PxTSC and V
IV
O- PxTSCm systems 
{I = 0.10 M (KCl) in 30% (w/w) DMSO, 70% (w/w) H2O}. Unit of the coupling constants (A) 
is 10-4 cm-1. (See g and A in Table S4.) 
 PxTSC  PxTSCm 
 go
a
 Ao
a
 g
b
 A
b
  go
a
 Ao
a
 g
b
 A
b
 
[V
IV
OLH2]
2+ 1.965(1) 93.9(1.3) 1.945(1) 165.7(0.2)  1.966(1) 93.2(1.0) 1.945(1) 165.3(0.1) 
[V
IV
OLH]
+ 1.969(1) 88.8(0.7) c c  1.971(1) 87.2(0.7) c c 
[V
IV
OL] 1.971(1) 87.6(0.7) 1.956(1) 157.9(0.2)  1.972(1) 86.4(1.1) 1.957(1) 157.8(0.5) 
[V
IV
OLOH]
-
 1.972(1) 83.4(1.6) -   1.972(3) 83.1(4) -  
a
 Room temperature. 
b
 In frozen solution. 
c
 Non assignable (see text) 
The two consecutive deprotonation processes result in only one main change in the EPR 
spectra, similarly as in the case of V
V 
(
51
V-NMR spectra, vide supra). Theoretically, 
deprotonation of the thiosemicarbazide moiety of the ligand would result in a major change in 
the spectrum, while that of the pyridoxal part would cause only a minor effect. Thus the 
spectral change cannot be assigned purely to the first or to the second deprotonation 
processes: microequilibrium processes have to be assumed. The pKa values calculated for 
[V
IV
OLH2]
2+
 from the room temperature (RT) EPR spectra are not in good agreement with 
data derived from the pH-potentiometric titrations (Table S5). Due to the overlapping 
processes and the small spectral difference between the RT EPR spectra of [V
IV
OLH]
+
 and 
[V
IV
OL] the pKa value of [V
IV
OLH]
+
 determined by EPR is unreliable. Furthermore, the 
assignment of the [V
IV
OLH]
+
 complex in the liquid nitrogen temperature (LNT) EPR spectra 
was not possible. 
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Fig. 7. Concentration distribution curves for the V
IV
O–PxTSC system {cVIVO = 1.0 mM; VIV : 
L = 1 : 2; T = 25.0°C, I = 0.10 M (KCl) in 30% (v/v) DMSO, 70% (v/v) H2O}. At pH > 5 the 
curves are only tentative due to the slow processes (dashed lines). 
As in case of the (51V) values the EPR parameters are similar for the [VIVOL] 
complexes of PxTSC/ PxTSCm (Table 3) and STSC (go= 1.972, Ao= 87.6 [35]). Notably, the 
effect of the N-terminal dimethylation is more significant than the exchange of 
salicylaldehyde to pyridoxal. 
At pH > 5 slow processes start, most likely due to the oxidation of the ternary hydroxido 
species which results in a decrease of the EPR signal intensities especially at pH >7. The 
[V
IV
OL(OH)
–
] species were assigned, but they probably exist at lower proportion than the 
speciation suggests at Fig. 7 (recalculation of the speciation curve using the hydrolysis 
constants of V
IV
O determined in pure water did not affect the speciation at pH below 8). 
3.5. Solution equilibria of copper
II
 complexes 
Formation of precipitates at pH > 6 in the presence of Cu
II
 ions in the mM concentration 
range (most likely neutral CuL complexes) hindered the pH-potentimetric titrations, thus 
complexation was studied only by UV–Vis spectrophotometric and EPR titrations at lower 
concentrations (cL = 100 M). In these UV–Vis spectra it could be observed that the ligand 
bands are strongly overlapped by the Cu
II–S charge transfer bands (Fig. S11).  
  
Fig. 8. Absorbance values measured at 404 nm for the Cu
II – PxTSC (1:1) system at pH 
between 1.0 and 12.5 together with the fitted curve (solid line). {cCu = cL = 0.1 mM; T = 
25˚C; I = 0.10 M (KCl); 30% (w/w) DMSO/H2O}. 
Comparison of the spectra recorded at pH 2 (which is the starting pH of the titrations) at 
various metal-to-ligand ratios with the spectra of the ligands (Fig. S11 for PxTSC) showed 
that they are significantly different. This indicates that complex formation processes with both 
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ligands start already at low pH. Therefore the pH was decreased down to pH 1.0 using 
individual samples in which KCl was partially or completely replaced by HCl to maintain the 
ionic strength constant. The spectrum recorded at pH 1 is still different from that of the metal-
free ligand (Fig. S12 for PxTSC), which means that most likely the complex does not 
decompose by decreasing the pH. Therefore, only a threshold limit for the log value of the 
[CuLH2]
2+
 complexes could be estimated on the basis of the spectral changes (Table 4).  
 
 
Fig. 9. Concentration distribution curves for the Cu
II–PxTSC system system {cCuII = 1.0 mM; 
Cu
II 
: L = 1 : 2; T = 25.0°C, I = 0.10 M (KCl) in 30% (v/v) DMSO, 70% (v/v) H2O}. 
Nevertheless, equilibrium constants for the deprotonation of the Cu
II
 complexes (pKa 
values) could be calculated with appropriate accuracy by the deconvolution of the recorded 
spectra (Table 2). The fits between the measured and calculated absorbance values are shown 
for the Cu
II
 – PxTSC system in Fig. 8 along with the corresponding concentration distribution 
curves (Fig. 9). On the basis of the estimated overall stability constants the relative Cu
II
 
binding abilities of PxTSC and its N-terminally dimethylated derivative cannot be compared 
directly since the complex formation equilibrium is superimposed by other accompanying 
equilibria, such as (de)protonation of the ligands. However, it can be concluded that both 
ligands are fairly efficient chelators for Cu
II
 in the whole pH range studied. In order to 
compare the stabilities, conditional stability constants (’) and pM values were calculated 
(pM stands for the negative logarithm of the equilibrium concentrations of the free metal ion 
under certain conditions). A higher value of log ’ and pM indicates stronger chelating 
ability. The conditional stability constants log ’ at pH = 7.4 (log ’ = pM in these cases if cM 
: cL = 1 : 2) estimated for the Cu
II
 – ligand systems (>16.9 and >17.1 for PxTSC and PxTSCm 
respectively, see also Table 2) are considerably higher than those of STSC (log ’ = 12.3 
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calculated based on data in [34]) or one of its derivatives (L-Pro-STSC, 2-hydroxy-3-methyl-
(S)-pyrrolidine-2-carboxylate-5-methylbenzaldehyde thiosemicarbazone, log ’ = 12.4 [44]). 
In addition, based on the literature data a lower conditional stability constant could be 
calculated for the most prominent -N-pyridyl TSC Triapine (log ’ = 10.6) [6]). Taken 
together, the pyridoxal derivatization results in the formation of Cu
II
 complexes with higher 
stability in the physiological pH range compared to the reference compound STSC. 
 
Fig. 10. Representative experimental (thick) and simulated (thin) EPR spectra for the Cu
II
 − 
PxTSC (1:1) system. {cCu = cL = 0.1 mM; T = 77 K; I = 0.10 M (KCl); 30% (w/w) 
DMSO/H2O}.  
In order to gain information about the coordination modes of the Cu
II
 complexes of the 
pyridoxal TSCs and their deprotonation processes (characterized by the pKa values, vide 
infra) frozen EPR spectra were recorded at various pH values for the Cu
II
 – PxTSC system. 
The latter system was chosen for the measurements owing to the much better solubility of the 
complexes compared to those of the dimethylated ligand. The fits between the experimental 
and the simulated spectra at two chosen pH values are depicted in Fig. 10. EPR spectra 
suggest that the presence of free Cu
II
 ions is negligible at pH ~2 and the metal ion mostly 
exists as complex [CuLH2]
2+
 and [CuLH]
+
 in good accordance with the findings of the UV–
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Vis titrations. Although the crystal structure of the dimeric [(Cu(HL)(OH2))2]Cl2 complex was 
published [27], based on our EPR spectra formation of monomer [CuLH]
+
 is suggested in 
solution. The latter becomes predominant between pH ~3.5 and ~5.5. However, formation of 
the neutral species [CuL] is accompanied by the loss of the EPR signal at pH > ~7 under the 
applied condition most probably as a result of aggregation processes in the frozen sample or 
due to the formation of dimeric species (UV–Vis titration data were not appropriate to 
distinguish between the formation of monomeric and dimeric species with the same metal-to-
ligand ratio.) Therefore anisotropic EPR parameters were calculated merely for the complexes 
[CuLH2]
2+
 and [CuLH]
+
 (Table 4). The obtained parameters (g and A values) indicate a 
tridentate coordination of the ligand PxTSC and a nearly square-planar geometry.  
Table 4 
Anisotropic EPR parameters obtained for Cu
II
 – PxTSC system from the simulation of EPR 
spectra with comparison of earlier published data 
 gx gy gz Ax 
a
 A
y 
a
 A
z 
a
 a
Nx 
/G a
Ny 
/G a
Nz 
/G 
PxTSC          
pH 2.3 2.035 2.053 2.226 21.2 16.7 175.7 17.7 15.9 8 
pH 3.8–5.0 2.030 2.052 2.205 20.1 20.8 177.7 20.6 15.5 8 
          
[CuL*H]b 2.033 2.051 2.224 22.5 24.3 176.5 17.1 6.1 6 
[CuL*]
- b
 2.025 2.050 2.204 24.3 15.6 181.6 19.5 15.3 6 
          
[CuL**H]
+ c
 2.035 2.054 2.228 22.2 22.4 174.7 5.7 17.2 6 
a
 Unit of the coupling constans (A) is 10-4 cm-1 
b
 L
*
 is L-Pro-STSC data taken from [44] 
c
 L
**
 is STSC data taken from [34] 
EPR parameter values of [CuLH2]
2+
 (Table 4) which is the dominant species at pH 2.3 
are rather similar to those of [CuLH]
+
 complexes of STSC [34] and L-Pro-STSC [44] 
suggesting similar coordination modes in solution. In these complexes the ligand binds 
through the deprotonated phenol O
–
,N
1
 and the thione S atoms (see MLH2 in Scheme 3), since 
the hydrazine N
2
H moiety is still protonated [44,58] in agreement with the X-ray crystal 
structure of the Cu
II
 complex of PxTSC [27]. [CuLH]
+
 (L = PxTSC) is formed most probably 
by deprotonation of the non-coordinating N
2
H moiety resulting in an (O
–
,N
1
,S
–
) coordination 
mode (see MLH in Scheme 3). Due to the higher negative charge, the increased ligand field 
“strength” the gz is decreased and the Az is increased after the deprotonation of the hydrazinic 
N
2
H moiety. The EPR parameters changed similarly in the case of L-Pro-STSC [44].  
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Comparing the deprotonation processes (Table 2) of the complexes formed with Cu
II
, V
V
 
and
 
V
IV
O it can be concluded that the first deprotonation (MLH2 → MLH), which belongs to 
the TSC part of the ligand, takes place at the most acidic pH in the case of V
V
. This can be 
explained by the higher electron deficiency around the metal ion due to the lack of d electrons 
in case of V
V
. The deprotonation of the pyridoxal nitrogen moiety takes place most probably 
in the subsequent [CuLH] → [CuL] step, which however, does not affect the coordination 
mode of PxTSC/PxTSCm (see ML in Scheme 3). At neutral pH the [CuL] species 
predominates. At higher pH the deprotonation of the water molecule in the fourth position 
results in the formation of [CuLH-1]
−
, which is regarded as a ternary hydroxido complex, 
[CuL(OH)]
− 
(see ML(OH) in Scheme 3). 
 
4. Conclusions 
Complexation of pyridoxal thiosemicarbazone (PxTSC) and its N-terminally 
dimethylated derivative (PxTSCm) with vanadium(IV/V) and copper(II) was studied in 
solution by the combined use of spectroscopic (
51
V-NMR, EPR, UV–Vis) techniques and pH-
potentiometry. Structures of the [V
V
O2(LH)] complexes of both ligands were characterized by 
single crystal X-ray diffraction studies. It was found that with V
IV
O and V
V
 metal ions only 
mono-ligand complexes were formed similarly to other thiosemicarbazones [34,35], or 
semicarbazones [45]. In contrast to Triapine, which in case of Cu
II
 forms bis-ligand 
complexes and a dinuclear Cu2L3 species [6], PxTSC and PxTSCm form merely mono 
complexes similarly to the reference compound STSC [34]. The pyridoxal moiety of the 
studied ligands results in an extra deprotonation step due to the non-coordinating pyridine-N 
compared to the behaviour of STSC. The experimental data (EPR, 
51
V-NMR) clearly show 
that this process takes place followed by the deprotonation of the non-coordinated N
2
H. The 
ring-N is quite far from the metal center and consequently its deprotonation does not 
significantly change the spectral behaviour of the complexes. However, deprotonation of the 
thiosemicarbazide moiety causes an electron rearrangement, resulting in a negatively charged 
coordinated sulphur atom, and the observed spectral changes become more pronounced.  
The extra positive charge of the protonated pyridoxal moiety makes the non-coordinated 
hydrazinic N
2
H moiety of PxTSC complexes more acidic (pKa is between 2–3) compared to a 
pKa of 3.5–4 in case of STSC complexes with the same metal ions [34,35]. However, these 
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deprotonation processes are completed at physiological pH and the complexes become neutral 
(or negatively charged in case of V
V
) similarly to STSC. 
 
Fig. 11. Comparison of the metal ion binding capability of PxTSC and STSC as a function of 
pH. (a) Conditional stability constant (log ’) of the ML complexes, M = CuII, VV and VIVO, 
L = PxTSC and STSC. (b) The difference between the conditional stability constants, log ’ 
of ML complexes of the two ligands: log ’(M(PxTSC))- log ’(M(STSC)) = 
log(’(M(PxTSC)/’(M(STSC)) The metal ion hydrolysis was not considered. The dashed 
lines in the case of V
IV
O represent higher uncertainty. {I = 0.10 M (KCl); 30% (w/w) 
DMSO/H2O}.  
The conditional stability constants at pH 7.4 (Table 2, Fig 11) are higher for all 
investigated metal ions compared to STSC, however there are significant differences in the 
increment: e.g. in case of V
V
 the difference is just above the detection limit (0.3 log unit), 
whereas in case of Cu
II
 a strong increase could be observed. The order of the increase of the 
conditional stability constants (Fig 11b) follows the decreasing Lewis acid hardness of the 
metal ions: V
V
 < V
IV
O < Cu
II
. In Fig 11b a clear maximum can be observed at around pH 4 in 
the case of Cu
II
 and V
V 
(not significant in case of V
IV
O). This can be explained by the fact 
that the pyridoxal moiety is deprotonated at a much higher pH in the Cu
II
 complex (pKa = 
6.22) than in the V
V
 (pKa = 5.15) and especially in the V
IV
O (pKa = 4.30) complexes.  In 
comparison STSC loose a proton with these metal ions with a pKa between pH 3.5 and 4. 
Most probable this extra stability increment between PxTSC/PxTSCm and STSC at mild 
acidic condition can be related to the salicylaldehyde/pyridoxal replacement and the 
increment would have been even higher if there were no other deprotonation processes of the 
complexes. So the final conclusions are that the salicylaldehyde/pyridoxal replacement has 
the strongest effect under mild acidic conditions, however, in case of Cu
II
 also at 
physiological pH a distinctly increased stability could be observed. Unfortunately the V
IV
O 
complexes are not stable enough to avoid hydrolysis completely at neutral pH. 
 
a b 
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5. Abbreviations 
TSC  thiosemicarbazone 
PxTSC pyridoxal thiosemicarbazone  
PxTSCm pyridoxal-N
3
,N
3
-dimethylthiosemicarbazone 
STSC  salicylaldehyde thiosemicarbazone 
SSC  salicylaldehyde semicarbazone 
L-Pro-STSC 2-hydroxy-3-methyl-(S)-pyrrolidine-2-carboxylate-5-methylbenzaldehyde 
thiosemicarbazone 
DMSO dimethyl sulfoxide 
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